Genpact Total Liab from 2010 to 2025

G Stock  USD 53.04  0.64  1.22%   
Genpact's Total Liabilities is increasing over the last several years with slightly volatile swings. Total Liabilities is predicted to flatten to about 1.6 B. Total Liabilities is the total amount of all liabilities that Genpact Limited has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2005-12-31
Previous Quarter
2.9 B
Current Value
2.6 B
Quarterly Volatility
913.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Genpact financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genpact's main balance sheet or income statement drivers, such as Depreciation And Amortization of 100.3 M or Interest Expense of 31 M, as well as many indicators such as Price To Sales Ratio of 2.29 or Dividend Yield of 0.0234. Genpact financial statements analysis is a perfect complement when working with Genpact Valuation or Volatility modules.
  
Check out the analysis of Genpact Correlation against competitors.

Latest Genpact's Total Liab Growth Pattern

Below is the plot of the Total Liab of Genpact Limited over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Genpact's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genpact's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Genpact Total Liab Regression Statistics

Arithmetic Mean1,961,968,934
Geometric Mean1,663,856,508
Coefficient Of Variation43.04
Mean Deviation699,802,209
Median2,025,577,000
Standard Deviation844,439,466
Sample Variance713078T
Range2.9B
R-Value0.80
Mean Square Error280874T
R-Squared0.63
Significance0.0002
Slope141,045,829
Total Sum of Squares10696170.2T

Genpact Total Liab History

20251.6 B
20242.9 B
20232.6 B
20222.8 B
20213.1 B
2020B
20192.8 B

About Genpact Financial Statements

Genpact stakeholders use historical fundamental indicators, such as Genpact's Total Liab, to determine how well the company is positioned to perform in the future. Although Genpact investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genpact's assets and liabilities are reflected in the revenues and expenses on Genpact's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genpact Limited. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Liabilities2.9 B1.6 B

Currently Active Assets on Macroaxis

Check out the analysis of Genpact Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Data Processing & Outsourced Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.50)
Dividend Share
0.61
Earnings Share
2.85
Revenue Per Share
26.724
Quarterly Revenue Growth
0.089
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.